drugset / Trial / NCT01965730

Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery

NCT01965730

Phase 0 Terminated 8 enrolled University of Pennsylvania
RandomizedFactorialDouble-blindOther

Summary

This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 15 mg/kg
Subject Aminocaproic Acid Small molecule 25 mg/kg

Indications